News - Presidio Pharmaceuticals


Current filters:

Presidio Pharmaceuticals

Popular Filters

Presidio Pharma inks deal with Boehringer Ingelheim for hep C combo


Privately-held USA-based Presidio Pharmaceuticals has entered into a non-exclusive collaboration with…

Anti-viralsBI207127Boehringer IngelheimfaldaprevirPharmaceuticalPPI-668Presidio PharmaceuticalsResearch

M&A briefs: BioCryst/Presidio; Pfizer/Nestle; Teva


Shares of USA-based BioCryst Pharmaceuticals (Nasdaq: BCRX) saw its shares rocket as much as 80%, before…

BioCryst PharmaceuticalsFinancialHomeMergers & AcquisitionsNestlePfizerPresidio PharmaceuticalsTeva Pharmaceutical Industries

BioCryst and Presidio to merge, creating new competitor in HCV arena


USA drugmaker BioCryst Pharmaceuticals (Nasdaq: BCRX) has signed a definitive accord to acquire privately…

Anti-viralsBioCryst PharmaceuticalsMergers & AcquisitionsPharmaceuticalPresidio Pharmaceuticals

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top